CRISPR And Cas Gene Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2102

The Business Research Company offers in-depth market insights through CRISPR And Cas Gene Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence.

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp

Market Segmentation:
The crispr and cas gene market covered in this report is segmented -

1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)

Major Driver - Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth
A growing focus on personalized therapy is expected to propel the growth of the CRISPR and Cas gene markets going forward. Personalized therapy refers to a medical model that uses an individual's genetic profile to guide decisions made concerning the diagnosis, treatment, and prevention of disease. CRISPR and the Cas gene, particularly Cas9, are used in personalized medicine, enabling precise modifications to an individual's genetic material and holding promise for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the rising demand for personalized therapy will drive the growth of the CRISPR and Cas gene markets.

Competitive Landscape:
Major companies operating in the crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Top Trend - CRISPR-Based Cell-Based Gene Therapy Revolutionizes Treatment Landscape In The CRISPR And Cas Gene Market
Major companies operating in the CRISPR and Cas gene markets are developing innovative products such as CRISPR-based cell-based gene therapy to enhance product offerings and gain a competitive advantage. CRISPR-based cell-based gene therapy involves using the CRISPR gene-editing technology to modify or correct genetic material within cells, offering a targeted and potentially revolutionary approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, received approval for CASGEVY (exagamglogene autotemcel [exa-cel]) from the U.S. Food and Drug Administration (FDA). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy for the management of sickle cell disease (SCD) in individuals aged 12 and above who have recurrent vaso-occlusive crises. CASGEVY is a first-of-its-kind medication that has the potential to be a one-time transformational therapy for qualified sickle cell patients. CASGEVY administration necessitates specific training in stem cell transplantation, hence, Vertex is collaborating with experienced institutions to create a network of independently owned, approved treatment centers (ATCs) across the United States to provide CASGEVY to patients.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. CRISPR And Cas Gene Market Characteristics
3. CRISPR And Cas Gene Market Trends And Strategies
4. CRISPR And Cas Gene Market - Macro Economic Scenario
5. CRISPR And Cas Gene Market Size And Growth
…..
27. CRISPR And Cas Gene Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.